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There are numerous causes for slow or delayed wound healing. Because slowly healing wounds are often inflamed,
we quantitated the inflammatory chemokine, interleukin-8, produced by slowly healing human burn wounds and
compared this to interleukin-8 from healed wounds and normal intact skin. Interleukin-8 levels were increased signifi-
cantly in unhealed wounds (19.7 ng/ml) compared to healed wounds (7.7 ng/ml) or normal skin (5.7 ng/ml). Interleukin-
8 in these ranges was added to adult human keratinocytes and fibroblasts. Interleukin-8 significantly decreased
keratinocyte replication but had no effect on fibroblast replication. The rate or final degree of fibroblast populated
collagen lattice contraction was inhibited at interleukin-8 concentrations between 10 and 30 ng/ml, but not altered
at concentrations below 10 ng/ml and above 100 ng/ml. The concurrent application of indomethacin at 10 mg/ml
reversed this interleukin-8 induced inhibition. Interleukin-8 inhibited myosin ATPase activity, apparently by reducing the
phosphorylation of nonmuscle myosin light chain. We conclude that elevated levels of interleukin-8 may be found
during delayed healing, and these elevated interleukin-8 levels may directly contribute to retarded wound closure.
(WOUND REP REG 2000;8:216–225)
Wound healing is usually an orchestrated series of steps BSA Bovine serum albumin
beginning with inflammation, proceeding through matrix DMEM Dulbecco’s modified Eagle medium
synthesis and cell replication and followed by tissue re- ELISA Enzyme-linked immunosorbent assay
FBS Fetal bovine serummodeling and scar stabilization. The numerous cellular
FPCL Fibroblast populated collagen latticeand humoral interactions during these phases of wound
IL-8 Interleukin-8healing are complex and not completely understood.
MLC Myosin light chain
Evolving evidence shows a changing cascade of cell types MLCK MLC kinase
and functions related to released cytokines and growth PBS Phosphate buffered saline solution
PGE2 Prostaglandin E2factors. For example, macrophages migrate into the
SDS Sodium dodecyl sulfate
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closure. Yet, in the absence of inflammation, wound clo- Fibroblasts require mRNA and protein synthesis, as well
as the participation of microtubules, microfilaments, a2b1sure is retarded.3 Thus, the relationship between the in-
flammatory phase of wound healing and the eventual integrin surface receptors, and myosin-ATPase for opti-
mizing lattice contraction.18,20 A number of agents aresuccess of wound closure is not clear.
Interleukin-8 (IL-8) is a chemokine associated with reported to inhibit lattice contraction including IL-1a,
prostaglandin E2 (PGE2) and cholera toxin. IL-1a inducesacute inflammation that is elevated in human wounds.4,5
IL-8 is reported to modulate the functions of numerous the synthesis of PGE2 that promotes cAMP formation,
which in turn prevents the activation of myosin ATPaseinflammatory cells involved in the repair process6 and is
the most studied member of the a-subfamily of chemo- by blocking the phosphorylation of its regulatory peptide,
the myosin light chain.20 Indomethacin, a cyclooxygenasekines. This subfamily of chemokines is characterized by
a conserved tri-peptide near the N-terminus, containing inhibitor, blocks the production of PGE2 and restores
lattice contraction to control levels in the presence ofcysteines (C-X-C). IL-8 was discovered in 1987,7 and its
3-dimensional structure,8 gene location,9,10 receptor IL-1a.
Although IL-8 is known to be present in wounds, itsstructure and properties,11 as well as a variety of func-
tions have been elucidated.12 IL-8 is an 8–10 kDa protein actions within these wounds are not fully understood.
In this study we measured the concentration of IL-8 infound in the form of 2 active isomers; a 77 amino acid
form and the more active 72 amino acid isoform.4 The human healing wounds. Using in vitro wound healing
models, the effects of these measured IL-8 concentra-72 amino acid form is used in the experiments presented
here. Many cells, including monocytes/macrophages, tions on activities of wound healing were examined. It
is proposed that IL-8 has direct effects upon fibroblastsneutrophils, eosinophils, T-cells, keratinocytes, fibro-
blasts, astrocytes, endothelial cells and chondrocytes, and keratinocytes that are independent of the effects
mediated by inflammatory cells. These results suggest asecrete IL-8 either constitutively or in response to a vari-
ety of pro-inflammatory stimuli.4,13 IL-8 binds to specific mechanism whereby excessive inflammation may have
an inhibitory effect on normal wound healing.transmembrane receptors and produces cellular re-
sponses through G-protein; phospho-inositol and protein
kinase C mediated signaling mechanisms.14 This type of
MATERIALS AND METHODSsignaling is associated with changes in the organization
of fibroblast cytoskeletal stress fibers and focal adhe- Tissue biopsies were obtained from patients who had
sustained burn injuries more than 3 weeks previously.sions.15,16 IL-8 is a potent chemoattractant for keratino-
cytes, neutrophils as well as other leukocytes.17 Tumor All patients provided informed consent prior to partici-
pating in this study, and the protocol had been approvednecrosis factor-a, IL-1a, and IL-1b stimulate IL-8 produc-
tion in macrophages.12 IL-8 appears to have a pathophysi- by the University of Michigan Institutional Review Board.
All patients underwent burn wound treatment using stan-ological role in some human diseases17 and elevated
levels of IL-8 have been associated with increased inflam- dard protocols including daily antimicrobial dressings for
partial-thickness injuries, skin grafting for full-thicknessmation in skin diseases such as psoriasis.6 Finally, in-
creased levels of IL-8 have been reported within healing injuries, and twice-weekly biopsy for quantitative bacte-
rial counts. In some patients these treatments were notburn wounds.5
Fibroblasts both synthesize and organize collagen completely effective and small areas of nonhealing or
slow-healing wounds remained. Six of these woundsfibrils, processes essential for wound healing. An in vitro
model for the study of fibroblasts and collagen interac- were partial thickness injuries that did not heal within
three weeks as expected. These wounds were 2–4 cm intions is the fibroblast populated collagen lattice (FPCL)
model, first introduced by Bell and coworkers in 1979.18 diameter, a size that would normally be expected to heal
by contraction or re-epithelialization within 2–4 weeks.A FPCL is cast by mixing together fibroblasts, culture
medium containing serum and soluble collagen. When The remaining wounds were small full-thickness
wounds, 1–3 cm in diameter. They had lost graft fromthe temperature is raised to 37 7C the collagen polymer-
izes trapping the cells within the rapidly forming gel. infection or shear, been treated to clear infection, but
then did not heal as expected. All wounds that wereOver time, the FPCL undergoes a reduction in size called
lattice contraction, which can be used to quantify the infected as quantitated by bacterial counts greater than
105 bacteria per gram of tissue were not included in thisinteractions of fibroblasts and collagen. The forces re-
sponsible for lattice contraction are generated by fibro- study. Full-thickness punch biopsies, 6 mm in diameter
were obtained from healed and unhealed portions of theblasts as they pack collagen fibrils into denser bundles.19
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burn wounds and normal, uninjured skin from the same taining 2% calcium free FBS, and antibiotics.22 Complete
medium was supplemented with 0.6 2 10–6 M hydrocorti-individual. Each biopsy was incubated for 18 hours in 3
ml of MCDB 110 medium (Sigma Chemical Co., St. Louis, sone, 5 ng/ml epidermal growth factor, 5 mg/ml insulin
and 6 mg percentage bovine pituitary extract (CloneticsMO), supplemented with 0.2% bovine serum albumin
(BSA) and 2.5 mg/ml gentamicin (Sigma Chemical Co.) Corp., San Diego, CA). Keratinocytes were used at pas-
sage two or three.at 37 7C, 95% air and 5% CO2. The resulting conditioned
media were frozen for IL-8 levels.
Cell replication
Triplicate samples of keratinocytes or fibroblasts wereInterleukin-8 assay
plated into 12-well plates at a density of 50,000 cells perThe enzyme-linked immunosorbent assay (ELISA) for
well. The following day fresh media with or without theIL-8 was essentially that reported by DeForge and Re-
addition of varying concentrations of IL-8 was added.mick.21 Briefly, a rabbit IgG polyclonal antibody to recom-
New media and chemokine were added at two-day inter-binant mononuclear cell-derived (72 amino acid form)
vals. The cells were harvested on the designated dayshuman IL-8 was isolated with a protein A-agarose column
by trypsinization and cell number determined by using(Pierce, Inc., Rockford IL). ELISA plates (Nunc-Immuno
a Coulter Counter.Plate Maxisorb, Inc., Neptune, NJ) were coated with 50
ml/well of anti-IL-8 monoclonal antibody (R & D Systems,
Collagen preparation
Minneapolis, MN) diluted to 1 mg/ml and incubated over-
Native collagen was acetic acid extracted from rat-tail
night at 4 7C. The plates were washed with PBS con-
tendon as previously described.23 Briefly, 0.5 M acetic
taining 0.05% v/v polysorbinate 20 (Tween-20) to block
acid solubilized collagen was centrifuged, precipitated
the reaction. PBS containing 2% BSA was added for 1–2
by adding NaCl (10% w/v), centrifuged and the collagen
hours at room temperature. The plates were washed,
pellet re-suspended in 0.1 M acetic acid. The collagen
biotinylated rabbit antihuman IL-8 antibody was added
solution was exhaustively dialyzed against 1 mM HCl
for 30 minutes, then avidin-horse-radish peroxidase
at 4 7C, frozen, lyophilized, re-suspended in 1 mM HCl
(Dako, Inc., Carpinteria, CA) at 1 : 5000 was added. After
(sterile) at 5 mg/ml and then stored at 4 7C. Based upon
30 minutes the plates were washed and substrate solution
sodium dodecyl sulfate-polyacrylamide gel electrophore-
(0.67 mg/ml orthophenylenediamine dichloride, 0.0125%
sis (SDS-PAGE) analysis, only collagen protein was de-
H2O2 in 0.25 mM citrate phosphate buffer, pH 5.0) was tectable by Coomassie Brilliant Blue staining.
added. Color development was stopped by adding 50 ml
3 M H2SO4 after 4–5 minutes. The absorbance at 490 nm FPCL contraction
on an ELISA reader was used to determine the concentra- FPCL in a total volume of 2 ml were cast by mixing
tions of IL-8 based upon a standard curve prepared with together freshly trypsinized fibroblasts (100,000) with
human recombinant IL-8 (R & D Systems). The lower complete DMEM and 2.5 mg collagen. Aliquots of 0.5 ml
limit of sensitivity for the assay was 45 pg/ml. of the mixture were added to wells of a 24-well tissue
culture dish. The dish was placed in a 37 7C incubator
Cell culture with 95% air and 5% CO2. Under these conditions, the
All cell strains were derived from discarded human skin. collagen/fibroblast mixture polymerized in less than 90
Two human dermal fibroblast lines were derived from seconds. Any additions were made in 10 ml aliquots and
newborn foreskin explant outgrowths. Fibroblasts were were added to the cell suspension prior to the addition
maintained in monolayer with Dulbecco’s modified Eagle of collagen. The treatment groups were: Control, PBS;
medium (DMEM) containing 10% fetal bovine serum IL-8 alone at 1, 3, 10, 30, 100 or 300 ng/ml; and a combina-
(FBS, Gibco-Life Science Technologies, Gaithersburg, tion of IL-8 (30 ng/ml) and indomethacin (10 mg/ml, Sigma
MD), 2 mM L-glutamine and 20 mg/ml gentamicin (‘‘com- Chemical Co.).
plete DMEM’’). Cells were used between their fifth and
sixteenth passage. Six human keratinocyte and two addi- Myosin ATPase activity assay
Four sets of sterile 22 2 22 mm glass cover slips in 35tional fibroblast strains were derived from skin discarded
from adult women undergoing breast reduction. The skin mm Petri dishes containing 2 ml of complete DMEM with
plated fibroblasts (~5000) received 10 ml of either PBSwas treated in 0.15% trypsin, overnight, and the epidermis
removed by mechanical scraping with a scalpel blade. (control) or 60 ng (final concentration 30 ng/ml) of IL-8.
At 24 hours, the medium was removed, the coverslipsParticulate matter was removed by filtration through
nylon mesh and the cell suspension plated in complete rinsed with PBS, the cells permeabilized by serial glyc-
erol treatments of 50, 25, 12.5 and 5% glycerol (v/v).24medium (KGM, Clonetics Corp., San Diego, CA) con-
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Half of the coverslips were rinsed in PBS and immedi- ular Probes, Inc., Eugene, OR) and mounted in PBS:
glycerol 9:1 under a coverslip. Fibroblasts within theately fixed in 4% paraformaldehyde for 5 minutes, rinsed
and retained in PBS. The remaining coverslips had the lattices were viewed and photographed with an Olympus
INT-2 microscope equipped with phase contrast and fluo-5% glycerol buffer replaced with 1 mM ATP in 5 mM
MgCl2, 30 mM KCl, 0.1 mM CaCl2 and 10 mM Tris-HCl rescent optics.
pH 7.0. After 10 minutes, the coverslips were washed in
PBS, fixed and rinsed as described above. Coverslips Statistical analysis
were viewed using an inverted microscope with phase The data on cytokine levels from tissue biopsies were
contrast optics and cell lengths measured by an eyepiece- analyzed using ANOVA for a randomized block design.
mounted micrometer. Measurements of at least 25 cells The values were log transformed prior to comparison to
from each coverslip were recorded from 3 coverslips compensate for data asymmetry. Pair-wise comparisons
from each treatment group (two at time 0, two with between healed, unhealed and normal tissue samples
ATP added for 10 minutes). The entire experiment was were made using the Tukey-Kramer adjustment for multi-
repeated twice. ple comparisons.
Comparison of FPCL contraction among treatment
Myosin light chain phosphorylation groups was made using one-way analysis of variance
Confluent 10 cm dishes of fibroblasts were incubated (ANOVA), with Dunnet’s test to compare each treatment
with complete DMEM supplemented with either: PBS group against the control group. Differences between
(control), IL-8 (30 ng/ml) or a combination of IL-8 (30 treatment groups in cell-contraction studies and densi-
ng/ml) and indomethacin (10 mg/ml). After 24 hours, the tometry reading of immunoblots were tested using the
medium was removed and the cells washed 3 times with Student’s t-test.
PBS. Cells were harvested by scraping and suspended The effect of IL-8 concentration on cell replication
in 1 ml of analysis buffer (20 mM Tris HCl, pH 7.5 con- was investigated using analysis of covariance (ANCOVA).
taining 4 mM EDTA, 137 mM NaCl, 10% glycerol, 1% The log of IL-8 concentration (plus 0.1, to avoid taking
Nonidet P-40, 0.15 U/ml aprotinin, 1 mM phenylmethyl- the log of zero) was used. A linear relationship between
sulfonyl fluoride, 10 mg/ml leupeptin, 100 mM sodium cell number and log IL-8 concentration was first as-
fluoride, 2 mM vanadate, and 10 mM sodium pyrophos- sumed. The six cell strains, the three plating times, and
phate; all from Sigma Chemical Co.). The cell lysates were the interaction between strains and plates were also en-
sonicated, boiled for 10 minutes, centrifuged, and insolu- tered into the analysis to adjust for known components
ble material discarded. The soluble protein concentration of human and laboratory variability. Because of an in-
were determined by the Bradford assay (BioRad Labora- crease in cell numbers between concentrations 0 and 1,
tories, Inc., Richmond, CA) and samples stored at – 70 7C. followed by a gradual decrease in cell numbers at the
For SDS-PAGE, 20 mg of protein from each sample was higher concentrations, the linear model was not ideal.
mixed with an equal volume of Laemmli buffer and elec- This pattern is displayed on a plot of cell number by log
trophoresis done on a 4–20% SDS gradient gel (BioRad IL-8 concentration, with a line that smoothly connects
Laboratories, Inc.). Proteins were transferred to Immobi- the values at each concentration. The line was calculated
lont membrane and probed with monoclonal antibodies using the loess algorithm.25 To adjust for this increasing,
to myosin light chain kinase (MLCK), myosin light chain then decreasing pattern in the ANCOVA, we added an
(MLC) or b-actin (all from Sigma Chemical Co.). Peroxi- indicator variable for concentration 4 0. This indicator
dase reaction using the ECL chemiluminescence kit assay variable was used to test the difference of this point from
(Amersham Life Technologies, Inc., Arlington Heights, IL) the line defined by the other IL-8 concentration values.
was employed following manufacturer’s instructions and
the band densities on X-ray film quantitated by densitome-
try.
RESULTS
The goal of this study was to ascertain whether the IL-8Cellular morphology
Fibroblasts residing in collagen lattices were examined concentrations produced by biopsies of slow or poorly
healing burn wounds would affect in vitro cell functionsby phase contrast and fluorescence microscopy for gross
appearance and orientation of cytoplasmic microfila- believed to be important for wound healing. Tissue biop-
sies were performed on 13 patients with slow healingments. FPCLs at 24 hours were fixed for 5 minutes in
4% paraformaldehyde, permeabilized with 0.1% Triton burn wounds for at least 3 weeks duration. In 12/13 cases
matched biopsies of normal skin were obtained andX-100 in PBS, then incubated with Rh-Phalloidin (Molec-
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Table 1. Interleukin-8 levels released from tissue biopsies
IL-8 concentrations (ng/ml)
Tissue source n Mean % SEM Ln Mean % SEM Range p vs. normal
Normal skin 12 5.69 5 1.69 1.06 5 0.41 0.51→20.0 —
Healed wound 9 7.73 5 2.54 1.42 5 0.46 0.29→20.4 0.55
Unhealed wound 13 19.67 5 6.23 2.60 5 0.24 2.95→89.7 0.002
9/13 cases matched biopsies of healed burn wound were than PBS controls (n 4 12 per group, p 4 0.001). IL-8
at 10 ng/ml or below and 100 ng/ml or above had noobtained.
significant effect upon FPCL contraction. Although IL-8
IL-8 levels inhibited the rate of FPCL during the initial 24 hours, it
The amount of IL-8 produced by tissue biopsies from did not affect the rate of FPCL contraction after that
normal skin and healed and unhealed wounds is pre- initial 24-hour period. This finding implied that added IL-8
sented in Table 1. There was a significant difference either has a short half-life or that it influenced fibroblasts
in IL-8 production among the 3 tissues assayed (p 4 during their initial encounter with polymerized collagen.
0.003 from ANOVA). The release of IL-8 by healed and The most inhibitory dose of IL-8 was in a narrow concen-
uninjured skin were similar, 5.7 ng/ml (range 0.1–20.1) tration range which was similar to the levels released by
vs. 7.7 ng/ml (range 0.2–20.4) (p 4 0.55). In contrast, slowly healing wound biopsies.
the level of IL-8 produced by biopsies of unhealed One possible mechanism for FPCL contraction retar-
wounds were significantly greater, 19.7 ng/ml (range dation is through the promotion of the arachidonic acid
3.0–89.7) (p 4 0.002 vs. uninjured). Subsequent experi- cascade and the release of prostaglandins.26 To investi-
ments utilized the concentration ranges of IL-8 produced gate that possibility, indomethacin (10 mg/ml), a cycloox-
by these biopsies. ygenase inhibitor, was added to lattices receiving IL-8 at
30 ng/ml. As shown in Figure 2, indomethacin attenuatedLattice contraction
the effects of IL-8 and reinstated lattice contraction toThe inclusion of IL-8 inhibited FPCL contraction at 24
control levels. Thus, indomethacin antagonized IL-8 re-hours (Figure 1). The suppression had an optimal dose
tardation of FPCL contraction.of 30 ng/ml, at which FPCL contraction was 23% less
Cell replication
The effects of IL-8 on cell replication were measured
using six strains of keratinocytes and two strains of fibro-
blasts. Cells were counted every other day until com-
pletely confluent, day 7–9 depending on the strain. The
differences in cell count were only significant at these
late time points; therefore, the concentration effects of
IL-8 on cell number are reported for these days (the last
measured day for all strains except one; the next-to-last
measured day for that strain).
IL-8 concentration had no effect on fibroblast repli-
cation (data not presented). Increasing IL-8 concentra-
tion significantly decreased the replication of epidermal
keratinocytes, p < 0.001 (Figure 3). Compared to control
(no IL-8 treatment), there was a modest, 12.5% (range
2–26), decrease at the 100 ng/ml concentration com-Figure 1. Dose response inhibitory effect of IL-8 on lattice contrac-
tion. FPCLs (n 4 12 for each dose) were incubated with increas- pared to control untreated cells. The decrease in final
ing doses of IL-8 and lattice contraction was measured at 24 cell count was greater, 21% (range 7–31), when com-
hours. Error bars represent 5 SD. The percentage inhibition of pared to the groups treated with 1–5 ng/ml IL-8, since
lattice contraction compared to the control mean is shown. The
these groups had the highest cell numbers. However,maximum inhibition (23%) was seen at an IL-8 concentration of
the increase in cell replication at low IL-8 concentra-30 ng/ml. All differences in inhibition were statistically significant
from the control group using ANOVA with Dunnett’s test. tions was not significant (p > 0.2). Cell strains exhibited
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Table 2. ATP-induced fibroblast contraction
Cell length* (m)
Group 0 minutes 10 minutes % Cell contraction†
Control 24.48 5 5.0 U 3.75 5 1.1 U 85%
IL-8 19.50 5 4.0 U 8.98 5 1.5 U 54%‡
n 4 84 for all groups.
*Cell length measured 0 and 10 minutes after the addition of ATP.
†[1 – (final length/initial length)] 2 100
‡Difference 4 31%, p 4 0.01 vs. control
Myosin ATPase activity
Permeabilized cells in monolayer culture contract when
ATP and its cofactors are added. The shortening of micro-
filaments through myosin ATPase activity induces cellFigure 2. The inhibitory effect of IL-8 on lattice contraction is
contraction and can be used as an assay of myosin AT-attenuated by indomethacin.FPCL (n 4 24 for each bar) were
incubated with PBS (white bars), IL-8 at 30 ng/ml (black stippling), Pase activity. Control fibroblasts contracted to 15% of
or a combination of IL-8 (30 ng/ml) and indomethacin (10 mg/ their initial length 10 minutes after adding ATP, whereas
ml) (gray stippling), and observed for 4 days. The graph depicts IL-8 treated cells contracted to only 46% of their initial
the average percentage contraction of the lattices over time.
length (p 4 0.01) (Table 2). Thus, IL-8 directly inhibitedError bars represent 5 SD. When compared to control, IL-8 at
myosin ATPase. This result suggests a mechanism to30 ng/ml inhibited lattice contraction 23% at each time point
measured (p 4 0.001), using ANOVA with Dunnett’s test, but the explain how IL-8 retards FPCL contraction.
addition of the indomethacin reversed the inhibitory effect of
Myosin light chain phosphorylationthe IL-8 to control levels of lattice contraction by 96 hours. Indo-
methacin alone had no significant effect on lattice contraction A potential mechanism linking retarded FPCL contrac-
(data not shown). tion and inhibited myosin ATPase activity is the phos-
phorylation state of MLC. Western Blot analysis of MLC,
MLCK and b-actin are shown in Figure 4. Equal concen-
trations of lysate were loaded, indicated by the density
of b-actin bands, an internal control for protein loading.
The levels of the enzyme MLCK were equivalent between
groups, indicating that IL-8 did not affect the levels of
this protein kinase, responsible for MLC phosphorylation
(Figure 4B). The levels of phosphorylated and nonphos-
phorated MLCs by immunoblotting showed differences
between treatment groups. The isoforms of MLC appears
in three bands, each designating a different phosphoryla-
tion state of the MLC.27 The top band, the essential MLC
band, is an unphosphorylated form that is constitutively
expressed; the middle band, is regulatory MLC, in its
unphosphorylated form; the lowest band is regulatory
MLC in its phosphorylated form. The higher the propor-
Figure 3. The effect of IL-8 on epidermal keratinocyte replication.
tion of phosphorylated regulatory MLC the greater the
Six strains of human keratinocytes were treated with the specified
myosin ATPase activity. The level of the phosphorylateddose of IL-8 for 7–9 days. There is a significant inhibitory effect of
regulatory MLC was negligible in the IL-8 alone treatmentIL-8 (p < 0.001, ANCOVA) on keratinocyte replication. The loess
algorithm (see text) was used to model this relationship. The cell group. The control and the indomethacin IL-8 combina-
numbers at zero concentration differed significantly from the tion treatment groups showed equivalent levels of phos-
decreasing linear trend of cell numbers with concentration phorylated regulatory MLC (Figure 4C). Therefore, IL-
greater than one (p 4 0.018). Values indicate mean 5 SE.
8 inhibited the phosphorylation of the regulatory MLC
independent of MLCK protein levels.
Cellular morphologysignificant (4-fold) differences in replication rate, but
the effect of IL-8 concentration was consistent across The induction of morphological changes in fibroblasts
residing in a collagen lattice by IL-8 was seen by phasestrains.
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Figure 4. Western blot analysis of MLCK and MLC in fibroblast cultures. Representative blots of the effect of IL-8 with and without
indomethacin on the expression of MLCK and MLC in fibroblasts in culture are shown. In each lane, 20 mg of protein was loaded.
In each blot, lane 1 is control, lane 2 is IL-8 (30 ng/ml) and lane 3 is the combination of IL-8 and indomethacin (10 mg/ml). As shown
in (A), blotting with b-actin confirmed equal loading of the gel. (B) The expression of MLCK among the three treatment groups is
also equal. (C) IL-8, alone, is shown to have a profound effect upon the phosphorylation of MLCs and this effect is blocked with
indomethacin.
contrast and fluorescent microscopy (Figure 5). By phase tion and matrix synthesis to remodeling. It is not surpris-
ing that disruption of this progression would causecontrast dermal fibroblasts in collagen were elongated
with a bipolar morphology (Figure 5A). In the presence deficiencies in healing. Clinically, wounds that display
inadequate inflammation, e.g., during steroid treatmentof IL-8, fibroblasts were less elongated and had a den-
dritic like appearance with multiple extensions (Figure or malnutrition, or excessive inflammation, e.g., during
infection or autoimmune disease, heal poorly. Simplisti-5B). As seen in Figure 6A, microfilaments in untreated
cells were organized as fine filaments. Cells within FPCL cally, these clinical observations have led to the hypothe-
sis that abnormal inflammation results in abnormaltreated with IL-8 (Figure 6B) showed few microfilaments
and the actin appeared as fluorescent aggregates. IL-8 healing. This article attempts to examine this possibility
more specifically. Excessive inflammation was quanti-hindered the organization of filamentous-actin into cyto-
plasmic microfilaments. This is in agreement with the tated by determining the concentration of a chemokine
generally thought to have little effect on noninflamma-actions of elevated prostaglandins.27
tory cells. The effects of chemokine treatment on wound-
associated cells provides a mechanistic rational for in-
DISCUSSION flammatory effects on delayed wound healing. Elevating
and/or prolonging the presence of IL-8 over an extendedNormal wound healing is an orchestrated activity which
proceeds from initial inflammation through cell replica- period of time appears to impair the repair process. We
Figure 5. Effect of IL-8 on cellular morphology shown using phase contrast microscopy of cells within a FPCL. (A) Control lattice showing
cells with an elongated bipolar morphology typical of fibroblasts within a collagen lattice. (B) Typical fibroblast within a collagen lattice
that has been treated with IL-8 showing multiple short actin extensions and a stellate appearance. (Original magnification 220).
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contraction and epithelialization within several weeks.
Here, prolonged or elevated levels of IL-8 appear to
impair the repair process. In vitro studies show elevated
IL-8 concentrations negatively affected both the mor-
phology and functions of fibroblasts and keratinocytes.
This suggests that the prolonged or elevated IL-8 levels
alter cell morphology and function. Because full-thick-
ness human wound closure involves epithelialization
and wound contraction,27 these are the specific cells
that achieve wound closure by re-epithelialization and
contraction; dysfunction of these cells will likely impair
wound closure. While there are probably numerous
reasons for wounds not to heal rapidly, we hypothesize
that excess inflammation is an important one in this
group of burn wounds.
Although these data show that a particular chemo-
kine, IL-8, is present in increased concentrations in de-
layed healing burn wounds, the cause for increased
concentrations of this cytokine is not known. Infected
wounds do not heal, but these wound were documented
by quantitative biopsy to not be infected. Nevertheless,
bacteria were likely present as colonizers of the wound
surface. Because the wounds lack a cornified epidermal
barrier, these low numbers of bacteria and their by-
products would interact with immunocompetent cells
within the wound. Endotoxin is a potent direct and indi-
rect stimulator of IL-8 release.21 Staphylococcal entero-
toxin A increases IL-8 synthesis in fibroblast-like
Figure 6. Effect of IL-8 on cellular morphology using fluorescent synovium cells.23 Alternately, tissue damage early after
phalloidin staining of cells within a FPCL. Rhodamine phalloidin burn injury also induces IL-8 production in the absence
was used to depict filamentous actin within the fibroblasts. (A)
of infection.5 The presence of a chemoattractant for neu-Control cells exhibit fine actin filaments throughout their cyto-
trophils, macrophages and lymphocytes4 such as IL-8, isplasm, whereas in (B), IL-8 treated cells show actin that has aggre-
gated in clumps and has lost its fine filamentous appearance. likely since these wounds are well populated by these
cell types. Non-healing wounds exhibit greater densities
of inflammatory cells that remain until wound closure
occurs. The levels of inflammatory cytokines and chemo-propose that an increase in IL-8 levels within burned skin
results in slowly healing wounds. kines are initially elevated in open wounds but decline as
healing advances.20 The present and our previous work5Delayed wound healing does not mean that these
wounds are chronic. Most clinicians have cared for document elevated levels of IL-8 during the inflammatory
phase of repair that appear to decline to normal levelspatients who have wounds that heal more slowly than
expected. In many cases the delay is related to infection, when the wound is healed. Taken together, this informa-
tion suggests that some inflammation is expected duringmalnutrition, or pre-existing disease. In some cases
these factors are not present but wound healing prog- normal wound healing and that concomitant trauma or
infection likely increases the amount of inflammationresses slowly or poorly. Our findings suggest that heal-
ing may be impaired but not prevented by changes in and its mediators that are present.
Wound contraction requires that fibroblasts organizethe delicate balance between numerous cell types and
the quantity of released products. Too much or too and compact collagen fibers into thicker fiber bundles.
The contraction of FPCL similarly depends upon fibro-little of certain products may upset that balance. The
present study focusses on analyzing biopsies of a partic- blast organization of collagen.19 Morphological changes
in cells induced by IL-8 include minimizing the promi-ular type of wound (burn) in apparently healthy patients
that sometimes did not heal within the usual time. nence of focal adhesion and microfilaments that are not
incorporated into stress fibers.28 These changes wouldNormally, such wounds would be expected to close by
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be expected to significantly alter the ability of cells to reflection of the chemokine concentration in the tissues
of a wound. Although there are problems with this as-interact with the surrounding matrix.
FPCL contraction is regulated by a variety of agents sumption, we do not believe that a better model exists.
Mediators are released by cells into tissues, where theyincluding prostanoids. The IL-8 induced morphological
changes in human fibroblasts suspended in collagen are can act in an autocrine or paracrine fashion. The IL-8
released into the medium by tissue biopsies is likely asimilar to those reported for PGE2.26 By Rh-Phalloidin
staining of F-actin microfilaments, IL-8 disrupts microfil- similar process. Secondly, the absolute concentration of
IL-8 determined in this model may not exactly reflect theaments in a manner consistent with that reported for
IL-8 treated endothelial cells.29 Impairment of myosin in vivo situation since there was only a 6-mm biopsy in 3
ml of medium. However, the range of IL-8 concentrationsATPase may be responsible for the inhibition of FPCL
contraction by IL-8 exposure. Myosin is both a structural found in the slowly healing wounds correlated with the
concentrations of IL-8 which decreased cellular activitiesprotein and an ATPase enzyme. Myosin has two pairs of
associated MLCs in which the phosphorylation of the associated with wound healing, a fact that support the
validity of the model. Quantitating the amount of cyto-regulatory pair maximizes ATPase activity. Phosphoryla-
tion of the regulatory MLCs is catalyzed by the kinase kine in a biopsy may not indicate the amount of cytokine
that is functionally active. Many mediators are stored inenzyme MLCK. It is proposed that IL-8 reduces myosin-
ATPase activity by blocking the phosphorylation of the the skin but are not active until released or activated.
Biopsies of different types may have different numbersregulatory MLCs by MLCK. In vivo, the inhibition of fibro-
blast myosin ATPase may reduce fibroblast migration of cells, cells of different lineages or vary in other ways
as a cause for the differences in cytokine production.into the wound site as well as reduce the organization
of collagen fiber bundles.24 These studies point to the Determining these differences will require a future study
to document the mechanisms for increased IL-8 produc-phosphorylation of the regulatory MLCs as a possible
mechanism for the effects of IL-8 directly on fibroblasts. tion in unhealed wounds. Nevertheless, whatever the
cause, unhealed burn wounds are producing higher levelsInhibition of these two activities will directly contribute
to retarded wound closure. of IL-8 per unit area and the cells in the tissue are exposed
to these increased concentrations of cytokines. Finally,The increased concentration of a single cytokine is
not likely to be sole reason for the impaired healing although the process of removing the tissue and placing
it into medium will likely activate some cells and cyto-observed in this group of slowly healing burn wounds.
Poorly healing and chronic wounds are a heterogenic kine, the relative effects from each tissue show clear
differences.group and are likely to result from a diverse group of
causes. Abnormal concentrations of other cytokines, In normal wound healing, an inflammatory response
is followed by the proliferative phase of repair withgrowth factors or mediators may contribute to disor-
dered healing or, alternatively, compensate for the inhibi- wound contraction and re-epithelialization, resulting in
wound closure. Our experimental data, coupled with clin-tion. For example, IL-1 also inhibits FPCL contraction
by fibroblasts.30 The effect of IL-8 on fibroblasts that ical observations suggest that overproduction of IL-8 in
a wound associated with increased or prolonged inflam-impair wound closure may be reversed by another
growth factor secreted later in the wound healing cas- mation may overwhelm the normal wound healing sys-
tem and impair closure. Furthermore, wound infection,cade. Transforming growth factor-b is present in healing
wounds and accelerates FPCL contraction.31 The ob- and resulting increased inflammation, would be detri-
mental to the ability of the host to progress to successfulserved restoration of FPCL contraction in the latter days
of culture and the delayed but eventual contraction of healing. This hypothesis provides an additional rationale
for the well-documented failure of infected wound towounds in patients may be due to the presence of this
factor or simply result from the turnover of IL-8 in FPCL heal. The removal of the inflammatory source would
eliminate the stimulus for the production of IL-8 andmodel and human tissues. Finally, the actual concentra-
tion of IL-8 in any specific wound is the consequence of other inflammatory cytokines, thereby allowing resump-
tion of the normal wound closure. Preventing the inva-ongoing synthesis and degradation. It will be necessary
to quantitate IL-8 production in serial biopsies of normal sion or promoting the exodus of inflammatory cells
would be expected to reduce the concentrations of IL-8.and abnormally healing tissue to better understand how
changes in the concentration of this chemokine effects This means that ongoing inflammation within nonhealing
wounds and the known increased synthesis and releasewound healing.
Every model has limitations. This one uses the chem- of IL-8 from these wounds would contribute to retarded
wound closure.okine concentration released by a tissue biopsy as a
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